Benitec Licenses Expressed RNAi Tech to Calimmune
March 08, 2012
Benitec Licenses Expressed RNAi Tech to Calimmune
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Benitec Looks to Outlicense IP While Avoiding Litigation Mistakes of Its Past
November 8, 2012 / Gene Silencing News - Calimmune Aims for Human Trial of HIV Drug in 2012
March 15, 2012 / Gene Silencing News - Benitec Closes Financing, Passes RAC Meeting as it Nears the Clinic
June 13, 2013 / Gene Silencing News - Benitec Plans to Advance Lung Cancer Drug into Clinic
June 6, 2013 / Gene Silencing News - Genable Receives FDA Orphan Drug Status for Ocular Disease Drug
April 18, 2013 / Gene Silencing News